The MHRA has strengthened addiction warnings for Z-drugs, benzodiazepines, and gabapentinoids after a review found risks of ...

Please provide your email address to receive an email when new articles are posted on . OSA severity improvement was based on placebo-adjusted change in apnea-hypopnea index during supine, non-rapid ...

Learn everything you need to know about Eszopiclone-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

A 12-week randomized, double-blind, placebo-controlled multicenter study sought to assess the safety and efficacy of eszopiclone in the treatment of 486 children and adolescents ages 6–17 with ...

A randomized trial evaluated the efficacy of eszopiclone (Lunesta) for insomnia in 410 women aged 40-60 years with onset of insomnia temporally associated with transition to menopause (Obstet Gynecol.

The US Food and Drug Administration (FDA) has lowered the recommended starting dose of the sleep aid eszopiclone (Lunesta, Sunovion Pharmaceuticals Inc) effective immediately, the agency announced ...

Details concerning the Eszopiclone medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and injections.

CDC: Prescription Opioid Use Stable Since 2006 When eszopiclone was given instead of zolpidem, no difference was observed on the polysomnogram diagnostic and positive airway pressure (PAP)-titration ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sepracor Inc. (Nasdaq: SEPR) today announced that the EMEA's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending to ...